Olpasiran

2 trials 1 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

1 Sponsors

22 Countries

Phase III

Phase III: 2

Oversight events:

1 serious breach across 1 trial

View oversight register →

Sponsors using this IMP

All trials

2 total

OCEAN(a)-CCTA - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction -Coronary Computed Tomography Angiography trial Recruiting

2025-521117-88-00 Phase III 6 countries Amgen Inc.
OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended

2022-501608-85-00 Phase III 22 countries Amgen Inc.

Showing 1–2 of 2 trials

← All drugs A–Z